3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
33
Lymphoma
17
Lymphoma, Large-Cell, Anaplastic
15
Hematologic Diseases
13
Lymphoma, Non-Hodgkin
10
Recurrence
9
Lymphoma, T-Cell
7
Lymphoma, T-Cell, Peripheral
6
Lymphoma, Large B-Cell, Diffuse
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell
4
Neoplasms
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphatic Diseases
3
Leukemia
3
Immunoblastic Lymphadenopathy
3
Sezary Syndrome
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Histologic Type
2
Lymphoproliferative Disorders
2
Lymphoma, Extranodal NK-T-Cell
2
Leukemia, Myeloid, Acute
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Enteropathy-Associated T-Cell Lymphoma
2
Waldenstrom Macroglobulinemia
1
Testicular Neoplasms
1
Nonseminomatous germ cell tumor
1
Interventions
Ipilimumab
98
pembrolizumab
84
Nivolumab
82
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Radiotherapy
12
Interferon alpha-2
12
spartalizumab
11
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
Brentuximab Vedotin
×
Clear all
No trials found.